Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Ocugen, Inc.
  6. Summary
    OCGN   US67577C1053

OCUGEN, INC.

(OCGN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/16/2021 09/17/2021 09/20/2021 09/21/2021 09/22/2021 Date
7.54(c) 7.93(c) 7.44(c) 7.55(c) 7.5(c) Last
7 862 363 14 999 229 9 260 843 7 418 827 5 757 417 Volume
+0.13% +5.17% -6.18% +1.48% -0.66% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -55,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -26,2x
Yield 2021 -
Sales 2022 136 M - -
Net income 2022 82,5 M - -
Net Debt 2022 - - -
P/E ratio 2022 18,1x
Yield 2022 -
Capitalization 1 491 M 1 491 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 11,0x
Nbr of Employees 15
Free-Float 97,5%
More Financials
Company
Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine is developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the... 
More about the company
Ratings of Ocugen, Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about OCUGEN, INC.
09/17OCUGEN INC : . Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
09/17INSIDER SELL : Ocugen
MT
09/16SOCIAL BUZZ : Wallstreetbets Stocks Largely in Negative Territory on Pre-Bell Thursday; Ir..
MT
09/15OCUGEN, INC. : Regulation FD Disclosure (form 8-K)
AQ
09/14OCUGEN : Thinking about buying stock in FuelCell Energy, Farmmi, Aterian, Vinco Ventures, ..
PR
09/10OCUGEN INVESTIGATION INITIATED BY FO : Kahn Swick & Foti, LLC Investigates the Officers an..
BU
09/08OCUGEN, INC. : Other Events (form 8-K)
AQ
09/07OCUGEN : to Present at Upcoming Citi and H.C. Wainwright Investment Conferences
AQ
09/01EXPERT SERIES : The truth about COVID-19 variants
PU
08/20OCUGEN INC : .áAnnounces Inducement Grants UnderáNasdaq Listing Rule 5635(c)(4)
AQ
08/13DEADLINE ALERT : Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit..
BU
08/13FINAL DEADLINE NOTICE : ROSEN, LEADING INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors..
PR
08/13THE LAW OFFICES OF FRANK R. CRUZ : Reminds Investors of Looming Deadline in the Class Acti..
BU
08/12OCGN INVESTOR ALERT : Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. Investors of..
BU
08/06OCUGEN : Q2 Net Loss Narrows
MT
More news
News in other languages on OCUGEN, INC.
09/17VENTE D'INITIÉS : Ocugen
07/15Ocugen, Inc. annonce le lancement d'une présentation en continu à Santé Canada pour COV..
05/06UN begrüßen US-Vorstoß zu Patentschutzes bei Corona-Impfstoffen
05/06CORONA-IMPFSTOFFE : Afrika setzt auf Unterstützer des US-Vorstoßes
05/06AKTIEN IM FOKUS 3 : Curevac und Biontech brechen ein - Droht Patentaussetzung?
More news
Analyst Recommendations on OCUGEN, INC.
More recommendations
Chart OCUGEN, INC.
Duration : Period :
Ocugen, Inc. Technical Analysis Chart | OCGN | US67577C1053 | MarketScreener
Technical analysis trends OCUGEN, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 7,50 $
Average target price 7,90 $
Spread / Average Target 5,33%
EPS Revisions
Managers and Directors
Shankar Musunuri Chairman & Chief Executive Officer
Sanjay Subramanian CFO, Secretary & Head-Corporate Development
Arun Upadhyay Vice President-Research & Development
Bruce D. Forrest Chief Medical Officer
Uday B. Kompella Independent Director
Sector and Competitors
1st jan.Capi. (M$)
OCUGEN, INC.309.84%1 491
MODERNA, INC.321.86%175 199
LONZA GROUP AG33.09%60 866
IQVIA HOLDINGS INC.44.97%49 103
CELLTRION, INC.-23.26%31 708
SEAGEN INC.-3.41%30 021